Transitional cell carcinoma cystoscopy and bladder biopsy: Difference between revisions
Line 6: | Line 6: | ||
==Cystoscopy and Biopsy== | ==Cystoscopy and Biopsy== | ||
*Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma | |||
* If the initial TURBT identifies muscle invasive (T2) disease, definitive therapy is generally indicated. | |||
* Cystectomy may also play a role in the management of patients with non-muscle invasive bladder cancer. | |||
* Any of the following represents a strong indication to proceed to cystectomy: | |||
* T1 tumors with lymphovascular invasion | |||
* Variant histologies, including micropapillary transitional cell carcinoma, sarcoma, squamous cell carcinoma, or adenocarcinomas | |||
* T1, grade 3 tumors that were incompletely resected | |||
* Prostatic duct/acinar CIS | |||
* Women with bladder neck and/or urethra CIS | |||
*Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma. | |||
*Cystoscopy may be performed to do biopsy | *Cystoscopy may be performed to do biopsy | ||
*Cystoscopy is the gold standard for surveillance in patients with a history of bladder cancer | *Cystoscopy is the gold standard for surveillance in patients with a history of bladder cancer |
Revision as of 13:52, 3 October 2019
Transitional cell carcinoma Microchapters |
Differentiating Transitional cell carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transitional cell carcinoma cystoscopy and bladder biopsy On the Web |
American Roentgen Ray Society Images of Transitional cell carcinoma cystoscopy and bladder biopsy |
FDA on Transitional cell carcinoma cystoscopy and bladder biopsy |
CDC on Transitional cell carcinoma cystoscopy and bladder biopsy |
Transitional cell carcinoma cystoscopy and bladder biopsy in the news |
Blogs on Transitional cell carcinoma cystoscopy and bladder biopsy |
Directions to Hospitals Treating Transitional cell carcinoma |
Risk calculators and risk factors for Transitional cell carcinoma cystoscopy and bladder biopsy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.
Cystoscopy and Biopsy
- If the initial TURBT identifies muscle invasive (T2) disease, definitive therapy is generally indicated.
- Cystectomy may also play a role in the management of patients with non-muscle invasive bladder cancer.
- Any of the following represents a strong indication to proceed to cystectomy:
- T1 tumors with lymphovascular invasion
- Variant histologies, including micropapillary transitional cell carcinoma, sarcoma, squamous cell carcinoma, or adenocarcinomas
- T1, grade 3 tumors that were incompletely resected
- Prostatic duct/acinar CIS
- Women with bladder neck and/or urethra CIS
- Cystoscopy may be helpful in the diagnosis of transitional cell carcinoma.
- Cystoscopy may be performed to do biopsy
- Cystoscopy is the gold standard for surveillance in patients with a history of bladder cancer
- To view histopathologic characteristic features of all transitional cell carcinoma, click here